376 (PB364): Targeting TGF-β signaling components to ameliorate Palbociclib resistance in breast cancer

Ali M, Itoh Y, Heldin CH, Moustakas A

Eur. J. Cancer 211 (-) 114889 [2024-10-00; online 2024-10-00]

DOI 10.1016/j.ejca.2024.114889

Crossref 10.1016/j.ejca.2024.114889


Publications 9.5.1